1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZYX CTRPv2 pan-cancer AAC -0.11 0.001
mRNA ZSCAN29 CTRPv2 pan-cancer AAC 0.1 0.006
mRNA ZSCAN21 CTRPv2 pan-cancer AAC 0.1 0.003
mRNA ZPR1 CTRPv2 pan-cancer AAC -0.095 0.006
mRNA ZPBP2 CTRPv2 pan-cancer AAC 0.12 0.0002
mRNA ZNRF1 CTRPv2 pan-cancer AAC -0.099 0.004
mRNA ZNRD1 CTRPv2 pan-cancer AAC -0.13 0.0005
mRNA ZNF92 CTRPv2 pan-cancer AAC 0.1 0.003
mRNA ZNF853 CTRPv2 pan-cancer AAC 0.091 0.01
mRNA ZNF831 CTRPv2 pan-cancer AAC 0.087 0.009
Download CSV